Skip to main content
Top
Published in: Journal of Gastrointestinal Surgery 9/2013

01-09-2013 | Original Article

Patterns of Consultation and Treatment of Patients with Hepatocellular Carcinoma Presenting to a Large Academic Medical Center in the US

Authors: Sylvie Stacy, Omar Hyder, David Cosgrove, Joseph M. Herman, Ihab Kamel, Jean-Francois H. Geschwind, Ahmet Gurakar, Robert Anders, Andrew Cameron, Timothy M. Pawlik

Published in: Journal of Gastrointestinal Surgery | Issue 9/2013

Login to get access

Abstract

Background

Management of hepatocellular carcinoma (HCC) often involves many subspecialist providers, as well as a broad range of treatment options. This study sought to evaluate referral and treatment patterns among patients with HCC at a large academic medical center.

Methods

Data from our cancer registry between 2003–2011 were abstracted on 394 patients who were primarily diagnosed/treated for HCC at Johns Hopkins Hospital (JHH); data on patients who were diagnosed/treated with HCC elsewhere and who received secondary treatment at JHH (n = 391) were also abstracted for comparison purposes.

Results

Among the main cohort, the most common specialties to be consulted were surgery (n = 225, 57.1 %), gastroenterology (n = 225, 57.1 %), and interventional radiologist (n = 206, 52.3 %), while only 96 (24.4 %) were referred to medical oncology. Factors associated with surgical consultation included younger age (odds ratio (OR) 3.35, 95 % CI 1.62–6.92), tumor size <5 cm (OR 1.82, 1.09–3.02), and unilobar disease (OR 2.94, 1.31–6.59) (all P < 0.05). Patients initially diagnosed/treated elsewhere had larger tumors (4 vs. 6 cm), bilateral disease (19.2 vs. 26.8 %), and were more likely to be seen by interventional radiology (all P < 0.05)

Conclusions

Most patients were seen by surgeons, gastroenterologists, or interventional radiologists, with only a minority being seen by medical oncologists. Referral patterns depended on patient-level factors, as well as extent of disease.
Literature
1.
go back to reference Bruix J, Sherman M. American association for the study of liver diseases. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53(3):1020-2.PubMedCrossRef Bruix J, Sherman M. American association for the study of liver diseases. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53(3):1020-2.PubMedCrossRef
2.
go back to reference El-Serag HB. Epidemiology of hepatocellular carcinoma in USA. Hepatol Res. 2007;37 Suppl 2S88-94. El-Serag HB. Epidemiology of hepatocellular carcinoma in USA. Hepatol Res. 2007;37 Suppl 2S88-94.
3.
go back to reference Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the US from 1975 to 2005. J Clin Oncol. 2009;27(9):1485-91.PubMedCrossRef Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the US from 1975 to 2005. J Clin Oncol. 2009;27(9):1485-91.PubMedCrossRef
4.
go back to reference Thomas MB, Zhu AX. Hepatocellular carcinoma: the need for progress. J Clin Oncol. 2005;23(13):2892-9.PubMedCrossRef Thomas MB, Zhu AX. Hepatocellular carcinoma: the need for progress. J Clin Oncol. 2005;23(13):2892-9.PubMedCrossRef
5.
go back to reference Nathan H, Bridges JF, Schulick RD, Cameron AM, Hirose K, Edil BH, Wolfgang CL, Segev DL, Choti MA, Pawlik TM. Understanding surgical decision making in early hepatocellular carcinoma. J Clin Oncol. 2011;29(6):619-25.PubMedCrossRef Nathan H, Bridges JF, Schulick RD, Cameron AM, Hirose K, Edil BH, Wolfgang CL, Segev DL, Choti MA, Pawlik TM. Understanding surgical decision making in early hepatocellular carcinoma. J Clin Oncol. 2011;29(6):619-25.PubMedCrossRef
6.
go back to reference Nathan H, Segev DL, Bridges JF, Massie AB, Cameron AM, Hirose K, Schulick RD, Choti MA, Pawlik TM. Influence of nonclinical factors on choice of therapy for early hepatocellular carcinoma. Ann Surg Oncol. 2013;20(2):448-56.PubMedCrossRef Nathan H, Segev DL, Bridges JF, Massie AB, Cameron AM, Hirose K, Schulick RD, Choti MA, Pawlik TM. Influence of nonclinical factors on choice of therapy for early hepatocellular carcinoma. Ann Surg Oncol. 2013;20(2):448-56.PubMedCrossRef
7.
go back to reference National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology - Hepatobiliary Cancers. Version 2. 2012. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology - Hepatobiliary Cancers. Version 2. 2012.
8.
go back to reference El-Serag HB, Siegel AB, Davila JA, Shaib YH, Cayton-Woody M, McBride R, McGlynn KA. Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study. Journal of Hepatology. 2006;44(1):158-166.PubMedCrossRef El-Serag HB, Siegel AB, Davila JA, Shaib YH, Cayton-Woody M, McBride R, McGlynn KA. Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study. Journal of Hepatology. 2006;44(1):158-166.PubMedCrossRef
9.
go back to reference Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology. 2002;35(3):519-24.PubMedCrossRef Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology. 2002;35(3):519-24.PubMedCrossRef
10.
go back to reference Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence-SEER 17 Regs Public Use, Nov. 2010 Sub (2000-2008)-Linked to County Attributes-Total US, 1969-2008 Counties. Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch; 2011. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence-SEER 17 Regs Public Use, Nov. 2010 Sub (2000-2008)-Linked to County Attributes-Total US, 1969-2008 Counties. Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch; 2011.
11.
go back to reference Nathan H, Hyder O, Mayo SC, Hirose K, Wolfgang CL, Choti MA, Pawlik TM. Surgical Therapy for Early Hepatocellular Carcinoma in the Modern Era: A 10-Year SEER-Medicare Analysis. Ann Surg. 2013. Nathan H, Hyder O, Mayo SC, Hirose K, Wolfgang CL, Choti MA, Pawlik TM. Surgical Therapy for Early Hepatocellular Carcinoma in the Modern Era: A 10-Year SEER-Medicare Analysis. Ann Surg. 2013.
12.
go back to reference van Walraven C, Austin PC, Jennings A, Quan H, Forster AJ. A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Medical Care. 2009;47(6):626-633.PubMedCrossRef van Walraven C, Austin PC, Jennings A, Quan H, Forster AJ. A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Medical Care. 2009;47(6):626-633.PubMedCrossRef
13.
go back to reference Reynolds GA, Chitnis JG, Roland MO. General practitioner outpatient referrals: do good doctors refer more patients to hospital? BMJ. 1991;302(6787):1250-2.PubMedCrossRef Reynolds GA, Chitnis JG, Roland MO. General practitioner outpatient referrals: do good doctors refer more patients to hospital? BMJ. 1991;302(6787):1250-2.PubMedCrossRef
14.
go back to reference Franks P, Clancy CM. Referrals of adult patients from primary care: demographic disparities and their relationship to HMO insurance. J Fam Pract. 1997;45(1):47-53.PubMed Franks P, Clancy CM. Referrals of adult patients from primary care: demographic disparities and their relationship to HMO insurance. J Fam Pract. 1997;45(1):47-53.PubMed
15.
go back to reference Steyerberg EW, Neville B, Weeks JC, Earle CC. Referral patterns, treatment choices, and outcomes in locoregional esophageal cancer: a population-based analysis of elderly patients. J Clin Oncol. 2007;25(17):2389-96.PubMedCrossRef Steyerberg EW, Neville B, Weeks JC, Earle CC. Referral patterns, treatment choices, and outcomes in locoregional esophageal cancer: a population-based analysis of elderly patients. J Clin Oncol. 2007;25(17):2389-96.PubMedCrossRef
16.
go back to reference Mandl LA. Determining who should be referred for total hip and knee replacements. Nat Rev Rheumatol. 2013. Mandl LA. Determining who should be referred for total hip and knee replacements. Nat Rev Rheumatol. 2013.
17.
go back to reference Haymart MR, Banerjee M, Yang D, Stewart AK, Griggs JJ, Sisson JC, Koenig RJ. Referral Patterns for Patients with High-Risk Thyroid Cancer. Endocrine Practice. 2013;1-19. Haymart MR, Banerjee M, Yang D, Stewart AK, Griggs JJ, Sisson JC, Koenig RJ. Referral Patterns for Patients with High-Risk Thyroid Cancer. Endocrine Practice. 2013;1-19.
18.
go back to reference Zhang J, Mavros MN, Cosgrove D, Hirose K, Herman JM, Smallwood-Massey S, Karnel I, Gurakar A, Anders R, Cameron A. Impact of a single-day multidisciplinary clinic on the management of patients with liver tumors. Current Oncology. 2013;20(2):e123.PubMedCrossRef Zhang J, Mavros MN, Cosgrove D, Hirose K, Herman JM, Smallwood-Massey S, Karnel I, Gurakar A, Anders R, Cameron A. Impact of a single-day multidisciplinary clinic on the management of patients with liver tumors. Current Oncology. 2013;20(2):e123.PubMedCrossRef
19.
go back to reference Cance WG, Stewart AK, Menck HR. The National Cancer Data Base Report on treatment patterns for hepatocellular carcinomas: improved survival of surgically resected patients, 1985-1996. Cancer. 2000;88(4):912-20.PubMedCrossRef Cance WG, Stewart AK, Menck HR. The National Cancer Data Base Report on treatment patterns for hepatocellular carcinomas: improved survival of surgically resected patients, 1985-1996. Cancer. 2000;88(4):912-20.PubMedCrossRef
20.
go back to reference Bufalino VJ, Masoudi FA, Stranne SK, Horton K, Albert NM, Beam C, Bonow RO, Vern Davenport RL Girgus M, Ronarow GC, Krumholz HM, Legnini MW, Lewis WR, Nichol G, Peterson ED, Rumsfeld JS, Schwamm LH, Shahian DM, Spertus JA, Woodard PK, Yancy CW. The American Heart Association’s recommendations for expanding the applications of existing and future clinical registries: a policy statement from the American Heart Association. Circulation. 2011;123(19):2167-79.PubMedCrossRef Bufalino VJ, Masoudi FA, Stranne SK, Horton K, Albert NM, Beam C, Bonow RO, Vern Davenport RL Girgus M, Ronarow GC, Krumholz HM, Legnini MW, Lewis WR, Nichol G, Peterson ED, Rumsfeld JS, Schwamm LH, Shahian DM, Spertus JA, Woodard PK, Yancy CW. The American Heart Association’s recommendations for expanding the applications of existing and future clinical registries: a policy statement from the American Heart Association. Circulation. 2011;123(19):2167-79.PubMedCrossRef
21.
go back to reference Facility Oncology Registry Data Standards. Chicago, IL: Commission on Cancer. 2012. Facility Oncology Registry Data Standards. Chicago, IL: Commission on Cancer. 2012.
22.
go back to reference Gliklich R, Dreyer N. Registries for Evaluating Patient Outcomes. Agency for Healthcare Research and Quality, Rockville, MD. 2010. Gliklich R, Dreyer N. Registries for Evaluating Patient Outcomes. Agency for Healthcare Research and Quality, Rockville, MD. 2010.
23.
go back to reference Kurtz JE, Heitz D, Enderlin P, Imbert F, Nehme H, Bergerat JP, Dufour P. Geriatric oncology, general practitioners and specialists: current opinions and unmet needs. Crit Rev Oncol Hematol. 2010;75(1):47-57.PubMedCrossRef Kurtz JE, Heitz D, Enderlin P, Imbert F, Nehme H, Bergerat JP, Dufour P. Geriatric oncology, general practitioners and specialists: current opinions and unmet needs. Crit Rev Oncol Hematol. 2010;75(1):47-57.PubMedCrossRef
24.
go back to reference Shah SA, Smith JK, Li Y, Ng SC, Carroll JE, Tseng JF. Underutilization of therapy for hepatocellular carcinoma in the medicare population. Cancer. 2011;117(5):1019-26.PubMedCrossRef Shah SA, Smith JK, Li Y, Ng SC, Carroll JE, Tseng JF. Underutilization of therapy for hepatocellular carcinoma in the medicare population. Cancer. 2011;117(5):1019-26.PubMedCrossRef
25.
go back to reference Nathan H, Frederick W, Choti MA, Schulick RD, Pawlik TM. Racial disparity in surgical mortality after major hepatectomy. J Am Coll Surgeons. 2008;207(3):312-319.CrossRef Nathan H, Frederick W, Choti MA, Schulick RD, Pawlik TM. Racial disparity in surgical mortality after major hepatectomy. J Am Coll Surgeons. 2008;207(3):312-319.CrossRef
26.
go back to reference Andaya AA, Enewold L, Zahm SH, Shriver CD, Stojadinovic A, McGlynn KA, Zhu K. Race and Colon Cancer Survival in an Equal-Access Healthcare System. Cancer Epidem Biomar. 2013. Andaya AA, Enewold L, Zahm SH, Shriver CD, Stojadinovic A, McGlynn KA, Zhu K. Race and Colon Cancer Survival in an Equal-Access Healthcare System. Cancer Epidem Biomar. 2013.
27.
go back to reference Spencer BA, Insel BJ, Hershman DL, Benson MC, Neugut AI. Racial disparities in the use of palliative therapy for ureteral obstruction among elderly patients with advanced prostate cancer. Support Care Cancer. 2013;1-9. Spencer BA, Insel BJ, Hershman DL, Benson MC, Neugut AI. Racial disparities in the use of palliative therapy for ureteral obstruction among elderly patients with advanced prostate cancer. Support Care Cancer. 2013;1-9.
28.
go back to reference Del Carmen MG, Avila-Wallace M. Effect of Health Care Disparities on Screening. Clin Obstet Gynecol. 2013;56(1):65-75.PubMedCrossRef Del Carmen MG, Avila-Wallace M. Effect of Health Care Disparities on Screening. Clin Obstet Gynecol. 2013;56(1):65-75.PubMedCrossRef
29.
go back to reference Luo R, Giordano SH, Zhang DD, Freeman J, Goodwin JS. The role of the surgeon in whether patients with lymph node-positive colon cancer see a medical oncologist. Cancer. 2007;109(5):975-82.PubMedCrossRef Luo R, Giordano SH, Zhang DD, Freeman J, Goodwin JS. The role of the surgeon in whether patients with lymph node-positive colon cancer see a medical oncologist. Cancer. 2007;109(5):975-82.PubMedCrossRef
30.
go back to reference Kirkpatrick HM, Aitelli CL, Qin H, Becerra C, Lichliter WE, McCollum AD. Referral patterns and adjuvant chemotherapy use in patients with stage II colon cancer. Clin Colorectal Cancer. 2010;9(3):150-6.PubMedCrossRef Kirkpatrick HM, Aitelli CL, Qin H, Becerra C, Lichliter WE, McCollum AD. Referral patterns and adjuvant chemotherapy use in patients with stage II colon cancer. Clin Colorectal Cancer. 2010;9(3):150-6.PubMedCrossRef
Metadata
Title
Patterns of Consultation and Treatment of Patients with Hepatocellular Carcinoma Presenting to a Large Academic Medical Center in the US
Authors
Sylvie Stacy
Omar Hyder
David Cosgrove
Joseph M. Herman
Ihab Kamel
Jean-Francois H. Geschwind
Ahmet Gurakar
Robert Anders
Andrew Cameron
Timothy M. Pawlik
Publication date
01-09-2013
Publisher
Springer US
Published in
Journal of Gastrointestinal Surgery / Issue 9/2013
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-013-2253-y

Other articles of this Issue 9/2013

Journal of Gastrointestinal Surgery 9/2013 Go to the issue